CD154 and IL-2 Signaling of CD4⁺ T Cells Play a Critical Role in Multiple Phases of CD8⁺ CTL Responses Following Adenovirus Vaccination

• Channakeshava Sokke Umeshappa,

  Current address: Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada

  Affiliations Cancer Research Unit, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, Departments of Oncology and Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

  ⨯
• Roopa Hebbandi Nanjundappa,

  Current address: Department of Microbiology, Immunology & Infectious Diseases, Health Research Innovation Centre, University of Calgary, Calgary, Alberta, Canada

  Affiliation Cancer Research Unit, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

  ⨯
• Yufeng Xie,

  Affiliation Cancer Research Unit, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

  ⨯
• Andrew Freywald,

  Affiliation Departments of Oncology and Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

  ⨯
• Yulin Deng,

  Affiliation Beijing Institute of Technology, Beijing, China

  ⨯
• Hong Ma,

  Affiliation Beijing Institute of Technology, Beijing, China

  ⨯
• Jim Xiang

  * E-mail: jim.xiang@saskcancer.ca

  Affiliations Cancer Research Unit, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, Departments of Oncology and Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, Beijing Institute of Technology, Beijing, China

  ⨯